Tenax Therapeutics Activates First Clinical Research Site for Phase 2 Pulmonary Hypertension Clinical Trial Life Science Investing
Corcept Therapeutics Announces First Patient Dosed in Phase 3 Trial of Relacorilant Life Science Investing
TRACON Pharmaceuticals Presents Data from Phase 2 Trial of TRC102 and Temodar Pharmaceutical Investing
Atara Biotherapeutics Announces Publication of Phase 1 Study Demonstrating Clinical Improvement Pharmaceutical Investing
PreveCeutical Confirms Encouraging Results from Sol-gel Applicator Trials for Achieving Direct Nose-to-Brain Delivery in an Adult Human Nasal Cast Cannabis Investing News
Life Science Big News Roundup: Lexaria Bioscience Launches ChrgD+; PreveCeutical Announces LOI with Crushedit LLC to Supply CBD Isolate Life Science Investing
Agios Presents Updated Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma Life Science Investing
Chi-Med Announces Phase III FALUCA Trial Results for Fruquintinib in Third-Line, Advanced Non-Small Cell Lung Cancer in China Pharmaceutical Investing
